The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis

This publication has 98 references indexed in Scilit:

• Red cell mass and plasma volume measurements in polycythemia:
  Cancer, 2005
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
  The Lancet, 2005
• Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome
  Genes, Chromosomes and Cancer, 2004
• Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH
  Leukemia, 2003
• Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
  Seminars in Hematology, 2001
• Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia
  The Hematology Journal, 2001
• BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner
  Cell, 1991
• Chromosome Studies in 104 Patients With Polycythemia Vera
  Mayo Clinic Proceedings, 1991